Novo shares slide as drugmaker lays out post-Wegovy growth strategy

The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.